Francoise Le Pimpec Barthes
Overview
Explore the profile of Francoise Le Pimpec Barthes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
910
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Daffre E, Porcher R, Iannelli A, Prieto M, Brouchet L, Falcoz P, et al.
Thorax
. 2024 Feb;
79(4):316-324.
PMID: 38359923
Introduction: Unlike most malignancies, higher body mass index (BMI) is associated with a reduced risk of lung cancer and improved prognosis after surgery. However, it remains controversial whether height, one...
2.
Etienne H, Pages P, Iquille J, Falcoz P, Brouchet L, Berthet J, et al.
ERJ Open Res
. 2024 Jan;
10(1).
PMID: 38259816
Introduction: Non-small cell lung cancer (NSCLC) is often associated with compromised lung function. Real-world data on the impact of surgical approach in NSCLC patients with compromised lung function are still...
3.
Alifano M, Daffre E, Brouchet L, Falcoz P, Le Pimpec Barthes F, Pages P, et al.
Lancet Reg Health Eur
. 2023 Jan;
26:100566.
PMID: 36591560
Background: Prognostic assessment in patients undergoing cancer treatments is of paramount importance to plan subsequent management. In resectable lung cancer availability of an easy-to use nomogram to predict long-term outcome...
4.
Wislez M, Mazieres J, Lavole A, Zalcman G, Carre O, Egenod T, et al.
J Immunother Cancer
. 2022 Oct;
10(10).
PMID: 36270733
Background: The IONESCO (IFCT-1601) trial assessed the feasibility of neoadjuvant durvalumab, for early-stage resectable non-small-cell lung cancer (NSCLC). Methods: In a multicenter, single-arm, phase II trial, patients with IB (≥4 ...
5.
Mangiameli G, Legras A, Arame A, Al Zreibi C, Mazzella A, Le Pimpec Barthes F
Minerva Surg
. 2022 May;
77(4):391-398.
PMID: 35575666
Introduction: Donor to recipient (D-R) matching in lung transplantation (LTx) is firstly directed by blood group (identity or compatibility), immunological status and morphological criteria. Sex matching is ignored and impact...
6.
Alifano M, Daffre E, Iannelli A, Brouchet L, Falcoz P, Le Pimpec Barthes F, et al.
Cancers (Basel)
. 2021 Sep;
13(18).
PMID: 34572801
Obesity could have a protective effect in patients with lung cancer. We assessed the prognostic role of preoperative BMI on survival in patients who underwent lung resection for NSCLC. A...
7.
Riquet M, Pricopi C, Mangiameli G, Arame A, Badia A, Le Pimpec Barthes F
J Thorac Dis
. 2018 May;
10(3):1220-1224.
PMID: 29707270
No abstract available.
8.
Riquet M, Pricopi C, Mangiameli G, Arame A, Badia A, Le Pimpec Barthes F
J Thorac Dis
. 2017 Dec;
9(11):4286-4290.
PMID: 29268493
No abstract available.
9.
Riquet M, Pricopi C, Mangiameli G, Arame A, Badia A, Le Pimpec Barthes F
J Thorac Dis
. 2017 Sep;
9(8):2271-2275.
PMID: 28932522
No abstract available.
10.
Compain F, Ait-Ammar N, Botterel F, Gibault L, Le Pimpec Barthes F, Dannaoui E
Mycopathologia
. 2017 Jun;
182(9-10):907-913.
PMID: 28580534
We report here a case of cavitary pneumonia due to Rhizopus homothallicus in a diabetic patient. This is the first proven case of R. homothallicus infection in Western countries and...